Group One Trading
NXTC icon

Group One Trading’s NextCure NXTC Stock Holding History

Group One Trading’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,717
Closed -$453K – 7836
2022
Q3 		$453K Hold
13,717
– – ﹤0.01% 3328
2022
Q2 		$774K Buy
+13,717
New +$716K ﹤0.01% 2985
2021
Q3 		– Sell
-1,125
Closed -$108K – 8591
2021
Q2 		$108K Hold
1,125
– – ﹤0.01% 5870
2021
Q1 		$135K Buy
+1,125
New +$163K ﹤0.01% 5380

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's NXTC Position: Q2 2023 in Review

Group One Trading sold out of NextCure (NXTC) in Q2 2023, closing a stake of 71 shares — an estimated $1.25K sold.

Group One Trading first reported a position in NXTC in Q4 2020 and held it in 5 quarters. The position peaked at $185K in Q4 2020. 43 funds tracked by Wall St. Rank hold NXTC as of Q2 2023.

  • Group One Trading reported no remaining NextCure position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 71 NextCure shares in Q2 2023, an estimated $1.25K.
  • Group One Trading first reported a position in NextCure in Q4 2020 and held it in 5 quarters.
  • Group One Trading's NextCure position peaked at $185K in Q4 2020.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.